Position in BCAB
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$237,201
New position
Shares Held
29,466
first reported quarter
Ownership
1.78%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026StoneX Group Inc. holds $2,168,513 across 16 Biotechnology names. BCAB ranks #4 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,482 | $661,772 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,469 | $473,297 | |
| 3 | HRMY |
Harmony Biosciences Holdings, Inc.
|
12,631 | $353,794 | |
| 4 | BCAB |
BioAtla, Inc.
This page
|
29,466 | $237,201 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
3,650 | $235,899 | |
| 6 | KALA |
KALA BIO, Inc.
|
12,984 | $112,311 | |
| 7 | CDXS |
Codexis, Inc.
|
14,096 | $22,976 | |
| 8 | RNXT |
RenovoRx, Inc.
|
12,728 | $12,855 |
All Filings in BCAB
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $237,201 | 29,466 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||